Anicia Cross-Robinson
Family · Loganville, GANPI 1114438132
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,653, 7.4 times the $356 reported in 2021.
Across 225 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$428
- Johnson & Johnson$421
- Teva Pharmaceuticals USA, Inc.$374
- E.r. Squibb & Sons, L.L.C.$364
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$362
- Supernus Pharmaceuticals, Inc.$262
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,54497%
- Education$1093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $428 |
| Johnson & Johnson | 15 | $421 |
| Teva Pharmaceuticals USA, Inc. | 27 | $374 |
| E.r. Squibb & Sons, L.L.C. | 20 | $364 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $362 |
| Supernus Pharmaceuticals, Inc. | 27 | $262 |
| Otsuka America Pharmaceutical, Inc. | 11 | $229 |
| Alkermes, Inc. | 14 | $214 |
| Neurocrine Biosciences, Inc. | 16 | $201 |
| Vanda Pharmaceuticals Inc. | 10 | $169 |
| Indivior Inc. | 6 | $166 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| Corium, LLC | 6 | $85 |
| Lundbeck LLC | 3 | $68 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| USWM, LLC | 2 | $39 |
| Eisai Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$133
How this compares
$3,653 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 11 | $194 |
| Quetiapine Fumarate | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other family in Loganville
- Amy HillLoganville$29K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.